FILTER

FILTERED INTERVIEW RESULTS

Paolo Paissoni

DIRECTOR OF INNOVATION AND BUSINESS DEVELOPMENT, PROCOS SPA
"We are currently building a new workshop in which we are specifically going to add small-scale lines to support clinical trial supply and generic product manufacturing."

Louis P. Kassa III

PRESIDENT AND CEO, PENNSYLVANIA BIOTECHNOLOGY CENTER (PABC)
"We want scientists to focus on science, and we offer them the equipment and services so they can do that."

Debbie Hart

PRESIDENT, BIONJ
"We used our voice to educate on the value of medical innovation and boasted the strength of New Jersey’s vibrant ecosystem, which was responsible for more than 50% of all novel FDA approvals in 2023."

Ajay Tandon

CEO, VEEDA CLINICAL RESEARCH LIMITED
"Although the US may have been ahead in technology adoption initially, India has been catching up rapidly."

Kimberly Young

NORTH AMERICA HEAD OF LIFE SCIENCES, CITI COMMERCIAL BANK
"Therapeutic areas that appeal to investors, strong management teams, relationships with large pharma, and the ability to generate data and advance pipelines are key to attracting funding."

Donna LaVoie

PRESIDENT AND CEO, LAVOIE HEALTH SCIENCE
"There is an insatiable demand for capital and there is too much innovation to fund."

Arda Ural

PARTNER & AMERICAS INDUSTRY MARKET LEADER, HEALTH SCIENCES AND WELLNESS, EY
"The biotech sector has room to grow. Oncology, blood disorders, immunology, inflammation, rare diseases, and neurology are key therapeutic areas attracting capital and fostering innovation."

Gil Roth

PRESIDENT, PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION (PBOA)
"There are signs of funding returning in the first half of this year, potentially revitalizing early-stage projects, and benefiting the CDMO sector."

Hernan Bazan

CEO AND CO-FOUNDER, SOUTH RAMPART PHARMA
“The best way to attract investment is with serious science and well-validated clinical mechanisms of action. An asset in the clinic with a well-described mechanism of action for how it works and peer-reviewed science, including NIH funding, helps with the validity.”

Steve Tallant

SENIOR DIRECTOR, SOLUTION MARKETING GROUP AT SYSTECH, A SOLUTIONS DIVISION OF MARKEM-IMAJE
"We are taking a physical supply chain and creating a digital twin of products and data moving through the chain."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Africa Energy 2024 - Pre-release

The pre-release edition of Africa Energy 2024 comprises analysis based on over 80 interviews with ministers and leading executives from IOCs, NOCs, independents, associations, investors and service providers, to provide an in-depth and holistic view of sub-Saharan Africa’s ever-evolving energy sector.

PARTNER EVENTS